Cargando…

1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team

BACKGROUND: The management of infective endocarditis (IE) by an expert medico-surgical team through multidisciplinary consultation meetings is now recommended. While it seems clear that it can improve the short-term prognosis of patients, long-term data are still scarce. METHODS: All patients hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Camou, Fabrice, Greib, Carine, Machelart, Irène, Dijos, Marina, Cornolle, Claire, Barandon, Laurent, Peuchant, Olivia, Wirth, Gaetane, Issa, Nahema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254177/
http://dx.doi.org/10.1093/ofid/ofy210.918
_version_ 1783373664660488192
author Camou, Fabrice
Greib, Carine
Machelart, Irène
Dijos, Marina
Cornolle, Claire
Barandon, Laurent
Peuchant, Olivia
Wirth, Gaetane
Issa, Nahema
author_facet Camou, Fabrice
Greib, Carine
Machelart, Irène
Dijos, Marina
Cornolle, Claire
Barandon, Laurent
Peuchant, Olivia
Wirth, Gaetane
Issa, Nahema
author_sort Camou, Fabrice
collection PubMed
description BACKGROUND: The management of infective endocarditis (IE) by an expert medico-surgical team through multidisciplinary consultation meetings is now recommended. While it seems clear that it can improve the short-term prognosis of patients, long-term data are still scarce. METHODS: All patients hospitalized between 2013 and 2017 in the three teaching hospitals of our center with an IE treated by the multidisciplinary team were followed prospectively at 1, 3, 6, and 12 months. The main objective was to determine the 1-year mortality of the entire cohort treated by the team. RESULTS: During the study, 493 patients had a certain or possible IE and the outcome at 1 year was known for 448 of them (4 lost to follow-up and 41 followed for less than 1 year): 254 had native valve IE (57%) and 194 had prosthetic valve IE (43%). The median age of IE patients was 69.3 years (155 patients were over 75 years old) and 329 (73%) were men. Healthcare-associated IE (HAIE) accounted for 47% of cases. A microorganism was isolated in 92% of cases (S. aureus = 24%), 252 patients (56%) had an embolic events and 68 (15%) had heart failure. The Charlson Median Comorbidity Index (ICC) was 5.0. Two hundred sixteen patients (48%) underwent surgery. The mortality rates at 1 month, 3 months, 6 months, and 1 year were, respectively, 14.1%, 19.0%, 23.2%, and 27.7%. The ICC at inclusion of patients who died at 1 year was 6.0 vs. 4.0 for survivors. Mortality at 1 year was significantly higher in case of HAIE (33% vs. 23%), documented S. aureus IE (39% vs. 24%), exclusive medical treatment (40% vs. 15%), and heart failure (43% vs. 25%). CONCLUSION: While the management of IE by an endocarditis team seems to improve the short-term prognosis of IE, 1-year mortality remains high as patients are increasingly older and have severe comorbidities. Our study confirms that early prognostic factors remain in the long term and that the prognosis is better in community-acquired IE with surgery. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6254177
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62541772018-11-28 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team Camou, Fabrice Greib, Carine Machelart, Irène Dijos, Marina Cornolle, Claire Barandon, Laurent Peuchant, Olivia Wirth, Gaetane Issa, Nahema Open Forum Infect Dis Abstracts BACKGROUND: The management of infective endocarditis (IE) by an expert medico-surgical team through multidisciplinary consultation meetings is now recommended. While it seems clear that it can improve the short-term prognosis of patients, long-term data are still scarce. METHODS: All patients hospitalized between 2013 and 2017 in the three teaching hospitals of our center with an IE treated by the multidisciplinary team were followed prospectively at 1, 3, 6, and 12 months. The main objective was to determine the 1-year mortality of the entire cohort treated by the team. RESULTS: During the study, 493 patients had a certain or possible IE and the outcome at 1 year was known for 448 of them (4 lost to follow-up and 41 followed for less than 1 year): 254 had native valve IE (57%) and 194 had prosthetic valve IE (43%). The median age of IE patients was 69.3 years (155 patients were over 75 years old) and 329 (73%) were men. Healthcare-associated IE (HAIE) accounted for 47% of cases. A microorganism was isolated in 92% of cases (S. aureus = 24%), 252 patients (56%) had an embolic events and 68 (15%) had heart failure. The Charlson Median Comorbidity Index (ICC) was 5.0. Two hundred sixteen patients (48%) underwent surgery. The mortality rates at 1 month, 3 months, 6 months, and 1 year were, respectively, 14.1%, 19.0%, 23.2%, and 27.7%. The ICC at inclusion of patients who died at 1 year was 6.0 vs. 4.0 for survivors. Mortality at 1 year was significantly higher in case of HAIE (33% vs. 23%), documented S. aureus IE (39% vs. 24%), exclusive medical treatment (40% vs. 15%), and heart failure (43% vs. 25%). CONCLUSION: While the management of IE by an endocarditis team seems to improve the short-term prognosis of IE, 1-year mortality remains high as patients are increasingly older and have severe comorbidities. Our study confirms that early prognostic factors remain in the long term and that the prognosis is better in community-acquired IE with surgery. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254177/ http://dx.doi.org/10.1093/ofid/ofy210.918 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Camou, Fabrice
Greib, Carine
Machelart, Irène
Dijos, Marina
Cornolle, Claire
Barandon, Laurent
Peuchant, Olivia
Wirth, Gaetane
Issa, Nahema
1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team
title 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team
title_full 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team
title_fullStr 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team
title_full_unstemmed 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team
title_short 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team
title_sort 1083. long-term prognosis of 448 infectious endocarditis followed by an endocarditis team
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254177/
http://dx.doi.org/10.1093/ofid/ofy210.918
work_keys_str_mv AT camoufabrice 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam
AT greibcarine 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam
AT machelartirene 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam
AT dijosmarina 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam
AT cornolleclaire 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam
AT barandonlaurent 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam
AT peuchantolivia 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam
AT wirthgaetane 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam
AT issanahema 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam